Moderna hails diversity of coronavirus trial participants

Biotech firm Moderna said Thursday that it had successfully recruited ethnic minorities, older people and those with underlying health issues for its COVID-19 vaccines trial, after it pushed to enrol groups most vulnerable to the virus.